These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8513854)

  • 21. Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability.
    Godbillon J; Vidon N; Palma R; Pfeiffer A; Franchisseur C; Bovet M; Gosset G; Bernier JJ; Hirtz J
    Br J Clin Pharmacol; 1987 Sep; 24(3):335-41. PubMed ID: 3663450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.
    Huang ML; Jusko WJ
    J Pharmacokinet Biopharm; 1990 Oct; 18(5):401-21. PubMed ID: 2266496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.
    Li X; DuBois DC; Almon RR; Jusko WJ
    J Pharmacol Exp Ther; 2020 Nov; 375(2):385-396. PubMed ID: 32883831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The non-linear pharmacokinetics of prednisone and prednisolone. III. Experiments using the rabbit as an animal model.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1988; 9(4):363-76. PubMed ID: 3207856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ketoconazole on the metabolism of prednisolone.
    Zürcher RM; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1989 Apr; 45(4):366-72. PubMed ID: 2639662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of prednisone and prednisolone.
    Frey BM; Frey FJ
    Clin Pharmacokinet; 1990 Aug; 19(2):126-46. PubMed ID: 2199128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroid pharmacodynamic modeling: osteocalcin suppression by prednisolone.
    Wald JA; Jusko WJ
    Pharm Res; 1992 Aug; 9(8):1096-8. PubMed ID: 1409384
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy.
    Bergamaschi S; Rusconi R; Gervasoni M; Rigamonti AE; Cella S; Bareggi SR
    Steroids; 2005 Oct; 70(11):787-9. PubMed ID: 16045952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of prednisolone and endogenous cortisol suppression in the elderly.
    Stuck AE; Frey BM; Frey FJ
    Clin Pharmacol Ther; 1988 Apr; 43(4):354-62. PubMed ID: 3356080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic interactions between zileuton and prednisone.
    Awni WM; Cavanaugh JH; Tzeng TB; Witt G; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():105-11. PubMed ID: 8620666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Free prednisolone pharmacokinetics predicted from total concentrations in patients with inflammatory - immunonologic conditions.
    Mangin O; Zheng Y; Bouazza N; Foissac F; Benaboud S; Lui G; Hirt D; Mouthon L; Tréluyer JM; Urien S
    Fundam Clin Pharmacol; 2020 Apr; 34(2):270-278. PubMed ID: 31625621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.
    Davis M; Williams R; Chakraborty J; English J; Marks V; Ideo G; Tempini S
    Br J Clin Pharmacol; 1978 Jun; 5(6):501-5. PubMed ID: 656293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers.
    Petri N; Borga O; Nyberg L; Hedeland M; Bondesson U; Lennernas H
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):71-9. PubMed ID: 16502766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation.
    Sæves I; Line PD; Bergan S
    Ther Drug Monit; 2012 Aug; 34(4):452-9. PubMed ID: 22777155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurements of prednisolone and some of its metabolites, in urine of patients after orthotopic liver transplantation, as a means of monitoring prednisolone absorption.
    Koopman BJ; van der Molen JC; Haagsma EB; Huizenga JR; Krom RA; Nagel GT; Gips CH; Wolthers BG
    J Clin Chem Clin Biochem; 1986 Nov; 24(11):831-9. PubMed ID: 3543199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
    Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
    Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.